0001730881-26-000004.txt : 20261106 0001730881-26-000004.hdr.sgml : 20261106 20261105174511 ACCESSION NUMBER: 0001730881-26-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261106 DATE AS OF CHANGE: 20261105 EFFECTIVENESS DATE: 20261106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Endogenex, Inc. CENTRAL INDEX KEY: 0001730881 ORGANIZATION NAME: EIN: 352587644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-516663 FILM NUMBER: 261528755 BUSINESS ADDRESS: STREET 1: 151 CHESHIRE LANE N, SUITE 400 CITY: PLYMOUTH STATE: MN ZIP: 55441 BUSINESS PHONE: 6513413805 MAIL ADDRESS: STREET 1: 151 CHESHIRE LANE N, SUITE 400 CITY: PLYMOUTH STATE: MN ZIP: 55441 FORMER COMPANY: FORMER CONFORMED NAME: DyaMX, Inc. DATE OF NAME CHANGE: 20180208 D/A 1 primary_doc.xml X0708 D/A LIVE 0001730881 Endogenex, Inc. 13755 1st Ave North, #100 PLYMOUTH MN MINNESOTA 55441 6513413805 DELAWARE Chip III, Inc. DyaMX, Inc. Corporation true Stacey Pugh c/o Endogenex, Inc. 13755 1st Ave North, #100 Plymouth MN MINNESOTA 55441 Executive Officer Director Juliet Bakker c/o Endogenex, Inc. 13755 1st Ave North, #100 Plymouth MN MINNESOTA 55441 Director Gerald Brunk c/o Endogenex, Inc. 13755 1st Ave North, #100 Plymouth MN MINNESOTA 55441 Director James Eadie c/o Endogenex, Inc. 13755 1st Ave North, #100 Plymouth MN MINNESOTA 55441 Director Doug Reed c/o Endogenex, Inc. 13755 1st Ave North, #100 Plymouth MN MINNESOTA 55441 Director Thomas Shehab c/o Endogenex, Inc. 13755 1st Ave North, #100 Plymouth MN MINNESOTA 55441 Director Krissy Wright c/o Endogenex, Inc. 13755 1st Ave North, #100 Plymouth MN MINNESOTA 55441 Executive Officer Other Health Care Decline to Disclose 06b true 0001730881-24-000003 2024-06-13 true true true false 0 144555034 132351879 12203155 $132,351,878.51 was sold in an initial closing and subsequent closings of the offering and an additional $12,203,155.49 may be sold upon the achievement of milestones or the occurrence of certain events. false 16 0 0 0 false Endogenex, Inc. Stacey Pugh Stacey Pugh Chief Executive Officer 2026-11-05